141 related articles for article (PubMed ID: 11140696)
1. Variability in gene expression patterns of Ewing tumor cell lines differing in EWS-FLI1 fusion type.
Aryee DN; Sommergruber W; Muehlbacher K; Dockhorn-Dworniczak B; Zoubek A; Kovar H
Lab Invest; 2000 Dec; 80(12):1833-44. PubMed ID: 11140696
[TBL] [Abstract][Full Text] [Related]
2. EWS-FLI1 fusion transcript structure is an independent determinant of prognosis in Ewing's sarcoma.
de Alava E; Kawai A; Healey JH; Fligman I; Meyers PA; Huvos AG; Gerald WL; Jhanwar SC; Argani P; Antonescu CR; Pardo-Mindan FJ; Ginsberg J; Womer R; Lawlor ER; Wunder J; Andrulis I; Sorensen PH; Barr FG; Ladanyi M
J Clin Oncol; 1998 Apr; 16(4):1248-55. PubMed ID: 9552022
[TBL] [Abstract][Full Text] [Related]
3. Gene expression profile of ewing sarcoma cell lines differing in their EWS-FLI1 fusion type.
Bandrés E; Malumbres R; Escalada A; Cubedo E; González I; Honorato B; Zarate R; García-Foncillas J; de Alava E
J Pediatr Hematol Oncol; 2005 Oct; 27(10):537-42. PubMed ID: 16217257
[TBL] [Abstract][Full Text] [Related]
4. Identification of various exon combinations of the ews/fli1 translocation: an optimized RT-PCR method for paraffin embedded tissue -- a report by the CWS-study group.
Stegmaier S; Leuschner I; Aakcha-Rudel E; Münch P; Kazanowska B; Bekassy A; Treuner J; Koscielniak E
Klin Padiatr; 2004; 216(6):315-22. PubMed ID: 15565546
[TBL] [Abstract][Full Text] [Related]
5. Transactivation of cyclin E gene by EWS-Fli1 and antitumor effects of cyclin dependent kinase inhibitor on Ewing's family tumor cells.
Li X; Tanaka K; Nakatani F; Matsunobu T; Sakimura R; Hanada M; Okada T; Nakamura T; Iwamoto Y
Int J Cancer; 2005 Sep; 116(3):385-94. PubMed ID: 15818598
[TBL] [Abstract][Full Text] [Related]
6. CD99 positivity and EWS-FLI1 gene rearrangement identify a breast tumor in a 60-year-old patient with attributes of the Ewing family of neoplasms.
Sezer O; Jugovic D; Blohmer JU; Turzynski A; Thiel G; Langelotz C; Possinger K; Kovar H
Diagn Mol Pathol; 1999 Sep; 8(3):120-4. PubMed ID: 10565682
[TBL] [Abstract][Full Text] [Related]
7. EWS-ERG fusion transcript produced by chromosomal insertion in a Ewing sarcoma.
Kaneko Y; Kobayashi H; Handa M; Satake N; Maseki N
Genes Chromosomes Cancer; 1997 Mar; 18(3):228-31. PubMed ID: 9071576
[TBL] [Abstract][Full Text] [Related]
8. Molecular characterization of the genomic breakpoint junction in a t(11;22) translocation in Ewing sarcoma.
Obata K; Hiraga H; Nojima T; Yoshida MC; Abe S
Genes Chromosomes Cancer; 1999 May; 25(1):6-15. PubMed ID: 10221334
[TBL] [Abstract][Full Text] [Related]
9. Impact of EWS-ETS fusion type on disease progression in Ewing's sarcoma/peripheral primitive neuroectodermal tumor: prospective results from the cooperative Euro-E.W.I.N.G. 99 trial.
Le Deley MC; Delattre O; Schaefer KL; Burchill SA; Koehler G; Hogendoorn PC; Lion T; Poremba C; Marandet J; Ballet S; Pierron G; Brownhill SC; Nesslböck M; Ranft A; Dirksen U; Oberlin O; Lewis IJ; Craft AW; Jürgens H; Kovar H
J Clin Oncol; 2010 Apr; 28(12):1982-8. PubMed ID: 20308673
[TBL] [Abstract][Full Text] [Related]
10. EWS-FLI1 fusion transcripts identified in patients with typical neuroblastoma.
Burchill SA; Wheeldon J; Cullinane C; Lewis IJ
Eur J Cancer; 1997 Feb; 33(2):239-43. PubMed ID: 9135495
[TBL] [Abstract][Full Text] [Related]
11. EAT-2 is a novel SH2 domain containing protein that is up regulated by Ewing's sarcoma EWS/FLI1 fusion gene.
Thompson AD; Braun BS; Arvand A; Stewart SD; May WA; Chen E; Korenberg J; Denny C
Oncogene; 1996 Dec; 13(12):2649-58. PubMed ID: 9000139
[TBL] [Abstract][Full Text] [Related]
12. Multiple chromosomal mechanisms generate an EWS/FLI1 or an EWS/ERG fusion gene in Ewing tumors.
Desmaze C; Brizard F; Turc-Carel C; Melot T; Delattre O; Thomas G; Aurias A
Cancer Genet Cytogenet; 1997 Aug; 97(1):12-9. PubMed ID: 9242212
[TBL] [Abstract][Full Text] [Related]
13. EWS/FLI-1 fusion signal inserted into chromosome 11 in one patient with morphologic features of Ewing sarcoma, but lacking t(11;22).
Batanian JR; Bridge JA; Wickert R; Vogler C; Gadre B; Huang Y
Cancer Genet Cytogenet; 2002 Feb; 133(1):72-5. PubMed ID: 11890993
[TBL] [Abstract][Full Text] [Related]
14. High-throughput RNAi screen in Ewing sarcoma cells identifies leucine rich repeats and WD repeat domain containing 1 (LRWD1) as a regulator of EWS-FLI1 driven cell viability.
He T; Surdez D; Rantala JK; Haapa-Paananen S; Ban J; Kauer M; Tomazou E; Fey V; Alonso J; Kovar H; Delattre O; Iljin K
Gene; 2017 Jan; 596():137-146. PubMed ID: 27760381
[TBL] [Abstract][Full Text] [Related]
15. Ewing sarcoma 11;22 translocation produces a chimeric transcription factor that requires the DNA-binding domain encoded by FLI1 for transformation.
May WA; Gishizky ML; Lessnick SL; Lunsford LB; Lewis BC; Delattre O; Zucman J; Thomas G; Denny CT
Proc Natl Acad Sci U S A; 1993 Jun; 90(12):5752-6. PubMed ID: 8516324
[TBL] [Abstract][Full Text] [Related]
16. EWS-FLI1 and EWS-ERG gene fusions are associated with similar clinical phenotypes in Ewing's sarcoma.
Ginsberg JP; de Alava E; Ladanyi M; Wexler LH; Kovar H; Paulussen M; Zoubek A; Dockhorn-Dworniczak B; Juergens H; Wunder JS; Andrulis IL; Malik R; Sorensen PH; Womer RB; Barr FG
J Clin Oncol; 1999 Jun; 17(6):1809-14. PubMed ID: 10561219
[TBL] [Abstract][Full Text] [Related]
17. FOXO1 is a direct target of EWS-Fli1 oncogenic fusion protein in Ewing's sarcoma cells.
Yang L; Hu HM; Zielinska-Kwiatkowska A; Chansky HA
Biochem Biophys Res Commun; 2010 Nov; 402(1):129-34. PubMed ID: 20933505
[TBL] [Abstract][Full Text] [Related]
18. EWS-FLI1 in Ewing's sarcoma: real targets and collateral damage.
Ban J; Siligan C; Kreppel M; Aryee D; Kovar H
Adv Exp Med Biol; 2006; 587():41-52. PubMed ID: 17163154
[TBL] [Abstract][Full Text] [Related]
19. The prognostic and therapeutic relevance of p27kip1 in Ewing's family tumors.
Matsunobu T; Tanaka K; Matsumoto Y; Nakatani F; Sakimura R; Hanada M; Li X; Oda Y; Naruse I; Hoshino H; Tsuneyoshi M; Miura H; Iwamoto Y
Clin Cancer Res; 2004 Feb; 10(3):1003-12. PubMed ID: 14871979
[TBL] [Abstract][Full Text] [Related]
20. Differential transactivation by alternative EWS-FLI1 fusion proteins correlates with clinical heterogeneity in Ewing's sarcoma.
Lin PP; Brody RI; Hamelin AC; Bradner JE; Healey JH; Ladanyi M
Cancer Res; 1999 Apr; 59(7):1428-32. PubMed ID: 10197607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]